Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
50 studies found for:    Open Studies | "Pruritus"
Show Display Options
RSS Create an RSS feed from your search for:
Open Studies | "Pruritus"
Need help? See RSS Feeds
Choose a feed type:
Show studies first received on any dateShow studies that were first received in the last 14 days
Show studies last updated date on any dateShow studies that were added or modified in the last 14 days
Rank Status Study
1 Recruiting Open Label Extension Study of Nalbuphine HCl ER in Hemodialysis Patients With Uremic Pruritus
Conditions: Uremic Pruritus;   Pruritus
Interventions: Drug: nalbuphine HCl ER 60mg BID;   Drug: nalbuphine HCl ER 90mg BID;   Drug: nalbuphine HCl ER 120mg BID
2 Recruiting Study of Nalbuphine HCl ER Tablets in Hemodialysis Patients With Uremic Pruritus
Conditions: Uremic Pruritus;   Pruritus
Interventions: Drug: nalbuphine HCl ER tablets 60 mg BID;   Drug: nalbuphine HCl ER tablets 120mg BID;   Drug: Placebo tablets BID
3 Recruiting Safety and Pharmacokinetics of IV CR845 in Hemodialysis Patients, and Its Efficacy in Patients With Uremic Pruritus
Conditions: Pruritus;   Uremic Pruritus
Interventions: Drug: Part A: Placebo;   Drug: Part A: CR845 0.5 mcg/kg;   Drug: Part A: CR845 1.0 mcg/kg;   Drug: Part A: CR845 2.5 mcg/kg;   Drug: Part B: Placebo;   Drug: Part B: CR845 1.0 mcg/kg
4 Recruiting Effect of Neurokinin-1 Receptor (NK1R) Antagonism on Pruritus in Patients With Sezary Syndrome
Conditions: Sezary Syndrome;   Pruritus
Interventions: Drug: Aprepitant;   Drug: Placebo
5 Unknown  Efficacy of Pregabalin in the Management of Chronic Uremic Pruritus
Condition: Uremic Pruritus
Interventions: Drug: Pregabalin;   Drug: Placebo
6 Not yet recruiting Pregabalin for the Treatment of Uremic Pruritus
Condition: Uremic Pruritus
Interventions: Drug: pregabalin 75mg daily for 12 weeks;   Drug: fexofenadine 60 mg daily for 12 weeks;   Drug: placebo
7 Unknown  Gabapentin - A Solution to Uremic Pruritus?
Conditions: Pruritus;   Uremia
Intervention: Drug: Gabapentin
8 Unknown  A Randomized-Withdrawal Phase 3 Study Evaluating the Safety and Efficacy of Oral Nalfurafine HCl (AC-820)in Subjects on Hemodialysis With Uremic Pruritus (Renal Itch)
Condition: Uremic Pruritus
Interventions: Drug: Nalfurafine HCl 2.5 µg;   Drug: Nalfurafine HCl 5.0 µg;   Other: Placebo
9 Recruiting Proof of Concept of VLY-686 in Subjects With Treatment-Resistant Pruritus Associated With Atopic Dermatitis
Condition: Treatment-resistant Pruritus Associated With Atopic Dermatitis
Interventions: Drug: VLY-686;   Drug: Placebo
10 Recruiting VPD-737 for Treatment of Chronic Pruritus
Condition: Chronic Pruritus
Interventions: Drug: VPD-737;   Drug: Placebo
11 Unknown  Treatment of Uremic Pruritus by Olive-omega 3 Ointment
Condition: Uremic Pruritus
Intervention: Procedure: application of ointment (olive-omega 3 ointment)
12 Recruiting Study of Using Long Acting Antihistamine to Treat Opioid Induced Itching
Condition: Pruritus
Interventions: Drug: Cetirizine;   Drug: Placebo or sugar pill
13 Unknown  Pruritus in Patients With Chronic Kidney Disease
Conditions: Kidney Failure, Chronic;   Pruritus
Intervention: Other: Questionnaire based on the McGill Pain Questionnaire
14 Not yet recruiting Atopic Dermatitis Itch
Condition: Cutaneous Nerves CNS Itch
Interventions: Drug: Clonidine;   Drug: Naltrexone
15 Recruiting Effects of Transcranial Direct Current Stimulation (tDCS) on Neuropathic Symptoms Following Burn Injury
Conditions: Burn Injury;   Chronic Pain;   Pruritus;   Itching
Intervention: Device: Transcranial direct current stimulation (tDCS)
16 Recruiting Comparison of Epidural Oxycodone and Epidural Morphine
Condition: Pruritus
Interventions: Drug: Opioid administration oxycodone;   Drug: Opioid administration morphine
17 Unknown  Acticoat Absorbent and BCT Antimicrobial for STSG Donor Site on Thigh
Conditions: Wound Healing;   Wound Infection;   Pain;   Pruritus;   Cicatrix
Interventions: Device: Acticoat Absorbent;   Device: BCT
18 Not yet recruiting Study of Nalbuphine HCl ER Tablets in Patients With Prurigo Nodularis
Conditions: Prurigo Nodularis;   Nodularis Prurigo;   Prurigo;   Pruritus
Interventions: Drug: nalbuphine HCl ER tablets 90 mg BID;   Drug: nalbuphine HCl ER tablets 180 mg BID;   Drug: Placebo tablets BID
19 Unknown  Vulvar Contact Dermatitis Resulting From Urine Incontinence
Conditions: Urinary Incontinence;   Vulvar Pruritus;   Vulvar Contact Dermatitis
Intervention: Other: Questionnaires, gynecological exam , vaginal smear, and measurement of urine leakage
20 Recruiting Prevention of Intrathecal Morphine Induced Pruritus: Comparison of Ondansetron and Palonosetron
Condition: Morphine Adverse Reaction
Interventions: Drug: Ondansetron;   Drug: Palonosetron

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years